Metformin and incretin-based therapies up-regulate central and peripheral Adenosine monophosphate-activated protein affecting appetite and metabolism

類似資料

• Long-term correction of type 1 and 2 diabetes by central leptin gene therapy independent of effects on appetite and energy expenditure
  著者:: Nakano, Masako, 等
  出版事項: (2012)
• Effects of dietary energy level on appetite and central adenosine monophosphate-activated protein kinase (AMPK) in broilers
  著者:: Hu, Xiyi, 等
  出版事項: (2019)
• Metformin as a Potential In Vitro Anticancer Modulator of Adenosine Monophosphate Kinase: A Review
  著者:: A. G. R. Greshamali Jinadasa, 等
  出版事項: (2024-01-01)
• Peripheral and central nutrient sensing underlying appetite regulation
  著者:: Augustine, Vineet, 等
  出版事項: (2018)
• Adenosine monophosphate kinase activator α‐lipoic acid: A promising therapeutic agent for metabolic syndrome?
  著者:: Lee, In‐Kyu
  出版事項: (2011)